http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006102007-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc093fd8fcf22005fd45adc85746175b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0a63347e039ac63788a0057d6e4b06e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-42
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C37-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-00
filingDate 2006-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0519b09ae787171e498a7de2e462764f
publicationDate 2006-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006102007-A3
titleOfInvention Methods for synthesizing alkylated and alkenylated quinone derivatives
abstract The present invention relates to methods for preparing quinone derivatives comprising reacting quinones with organoborane reagents to produce alkylated and alkenylated quinone derivatives. In one embodiment, the present invention provides processes comprising the reaction of mixed diaryl- and dimethylalkyl or alkenylboranes with p-benzoquinone, substituted p-benzoquinones, o-benzoquinones as well as napththquinones, and isomers and substituted derivatives thereof. The invention also provides methods and compositions to treat, prevent or ameliorate cell injury or cell death initiated by the enzyme sphingomyelinase, including but not limited to cell injury or cell death as a direct or secondary result of hypoxia (ischemia or stroke), radiation, chemotherapy agents, poisons, biological warfare agents, extremes in temperature (hot or cold), pressure, trauma and the like.
priorityDate 2005-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5202225-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408144
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226486129

Total number of triples: 20.